ImmunoCellular Therapeutics Ltd (IMUC)

0.38
0.01 1.43
AMEX : Health Care
Prev Close 0.39
Open 0.40
Day Low/High 0.36 / 0.41
52 Wk Low/High 0.20 / 0.64
Volume 3.78M
Avg Volume 592.00K
Exchange AMEX
Shares Outstanding 3.46M
Market Cap 1.21M
EPS -7.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of ImmunoCellular Therapeutics, Ltd. Shareholders And A Lead Plaintiff Deadline Of June 30, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ImmunoCellular Therapeutics, Ltd.

The Klein Law Firm Notifies Investors Of A Class Action Filed On Behalf Of ImmunoCellular Therapeutics, Ltd. Shareholders And A Lead Plaintiff Deadline Of June 30, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ImmunoCellular Therapeutics, Ltd.

IMMUNOCELLULAR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 In Immunocellular Therapeutics, Ltd. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ImmunoCellular Therapeutics, Ltd.

IMUC SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving ImmunoCellular Therapeutics, Ltd. And A Lead Plaintiff Deadline Of June 30, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who purchased ImmunoCellular...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of ImmunoCellular Therapeutics, Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of June 30, 2017 - IMUC

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of ImmunoCellular Therapeutics, Ltd.

IMMUNOCELLULAR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In ImmunoCellular Therapeutics, Ltd. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ImmunoCellular Therapeutics, Ltd.

IMUC EQUITY ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving ImmunoCellular Therapeutics, Ltd. And A Lead Plaintiff Deadline Of June 30, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who purchased ImmunoCellular...

IMUC LOSS NOTICE: Rosen Law Firm Reminds ImmunoCellular Therapeutics, Ltd. Of Important Deadline In Class Action - IMUC

Rosen Law Firm, a global investor rights law firm, reminds purchasers of ImmunoCellular Therapeutics, Ltd.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of ImmunoCellular Therapeutics, Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of June 30, 2017 - IMUC

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of ImmunoCellular Therapeutics, Ltd.

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. And Encourages Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against ImmunoCellular Therapeutics, Ltd.

INVESTOR ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd.

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against ImmunoCellular Therapeutics, Ltd.

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against ImmunoCellular Therapeutics, Ltd.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. - IMUC

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of ImmunoCellular Therapeutics, Ltd.

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

An SEC enforcement action uncovers the deep involvement and brazen misbehavior of biotech CEOs in an illegal stock promotion scheme.